跳至主要内容
临床试验/CTRI/2021/11/038228
CTRI/2021/11/038228已完成未知

COMPARISON OF EFFICACY AND TOLERABILITY OF LEVOCETIRIZINE WITH MONTELUKAST-LEVOCETIRIZINE COMBINATION AS AN ADD-ON THERAPY IN MIGRAINE PROPHYLAXIS?,-An open label, Prospective, Comparative Study

Madras medical college0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients diagnosed with Migraine headache as per ICHD-3 criteria
  • Patients fulfilling the criteria for the prophylaxis of Migraine
  • Age group of 18-60 years of age
  • Sex- Both male and female
  • Patients who are willing to participate in this study

排除标准

  • Patients with headache other than migraine
  • Patients with complicated migraine like ophthalmic, hemiplegic or migraine with brainstem aura
  • Patients with H/O severe drug allergy
  • Patients with H/O severe co-morbidities like hypertension, Coronary artery disease, uncontrolled Diabetes Mellitus, thyroid disease, renal or liver disease, asthma.
  • H/O any drug abuse or drug dependence
  • Patients with H/O any psychiatric illness
  • Pregnant ladies, lactating mothers and children less than 18 years of age

研究者

相似试验